<bill session="115" type="h" number="5219" updated="2019-11-15T21:20:52Z">
  <state datetime="2018-03-08">REFERRED</state>
  <status>
    <introduced datetime="2018-03-08"/>
  </status>
  <introduced datetime="2018-03-08"/>
  <titles>
    <title type="official" as="introduced">To require sellers of opioids at retail to verify the identity of the prospective purchaser and enter certain information about the purchase into the respective State's prescription drug monitoring system, and for other purposes.</title>
    <title type="short" as="introduced">Opioid Prescription Verification Act of 2018</title>
    <title type="short" as="introduced">Opioid Prescription Verification Act of 2018</title>
    <title type="display">Opioid Prescription Verification Act of 2018</title>
  </titles>
  <sponsor bioguide_id="D000619"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-03-08">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-03-08" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2018-03-09">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health information and medical records"/>
    <term name="Photography and imaging"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2018-03-08T05:00:00Z" status="Introduced in House">Opioid Prescription Verification Act of 2018

This bill requires retail distributors of opioids in states with prescription drug monitoring programs, for each opioid sale, to (1) verify the identity of the purchaser; and (2) enter into the program's system&#160;the name and address of the purchaser, the name and address of the patient for whom the opioid is prescribed, the name of the opioid, the quantity sold, and the date and time of the sale.</summary>
  <committee-reports/>
</bill>
